Cyclooxygenase-2 activity contributes to neuronal expression of cyclin D1 after anoxia/ischemia in vitro and in vivo

Molecular Brain Research

Volumn 132, Issue 1, 2004, Pages 31-37

  Wu Chen, Ren ^a   Zhang, Yuqing ^a   Rose, Marie E ^a   Graham, Steven H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GERIATRIC RESEARCH EDUCATION AND CLINICAL CENTER   (United States)

Author keywords

Cell cycle; Cyclin D1; Cyclooxygenase; Ischemia

Indexed keywords

5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; CYCLIN D1; CYCLOOXYGENASE 2; DNA FRAGMENT; FLAVOPIRIDOL; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; IN VITRO STUDY; IN VIVO STUDY; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR MECHANICS; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYCLIN D1; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLAVONOIDS; HYPOXIA-ISCHEMIA, BRAIN; INFARCTION, MIDDLE CEREBRAL ARTERY; NEURONS; NEUROPROTECTIVE AGENTS; NITROBENZENES; PIPERIDINES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 8844263102     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.08.020     Document Type: Article

References (42)

1. G. Almer, C. Guegan, P. Teismann, A. Naini, G. Rosoklija, A.P. Hays, C. Chen, and S. Przedborski Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis Ann. Neurol. 49 2001 176 185
2. K.I. Andreasson, A. Savonenko, S. Vidensky, J.J. Goellner, Y. Zhang, A. Shaffer, W.E. Kaufmann, P.F. Worley, P. Isakson, and A.L. Markowska Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice J. Neurosci. 21 2001 8198 8209
3. M. Asanuma, S. Nishibayashi-Asanuma, I. Miyazaki, M. Kohno, and N. Ogawa Neuroprotective effects of non-steroidal anti-inflammatory drugs by direct scavenging of nitric oxide radicals J. Neurochem. 76 2001 1895 1904
4. L. Bergeron, G.I. Perez, G. Macdonald, L. Shi, Y. Sun, A. Jurisicova, S. Varmuza, K.E. Latham, J.A. Flaws, J.C. Salter, H. Hara, M.A. Moskowitz, E. Li, A. Greenberg, J.L. Tilly, and J. Yuan Defects in regulation of apoptosis in caspase-2-deficient mice Genes Dev. 12 1998 1304 1314
5. J.C. Breitner, K.A. Welsh, M.J. Helms, P.C. Gaskell, B.A. Gau, A.D. Roses, M.A. Pericak-Vance, and A.M. Saunders Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs Neurobiol. Aging 16 1995 523 530
6. Y. Cao, and S.M. Prescott Many actions of cyclooxygenase-2 in cellular dynamics and in cancer J. Cell. Physiol. 190 2002 279 286
7. D.B. Drachman, and J.D. Rothstein Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis Ann. Neurol. 48 2000 792 795
8. G. Gasparini, R. Longo, R. Sarmiento, and A. Morabito Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol. 4 2003 605 615
9. M.P. Goldberg, H. Monyer, and D.W. Choi Hypoxic neuronal injury in vitro depends on extracellular glutamine Neurosci. Lett. 94 1988 52 57
10. S.H. Graham, and R.W. Hickey Cyclooxygenases in central nervous system diseases: a special role for cyclooxygenase 2 in neuronal cell death Arch. Neurol. 60 2003 628 630
11. E.K. Han, S.C. Ng, N. Arber, M. Begemann, and I.B. Weinstein Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis Apoptosis 4 1999 213 219
12. S.J. Hewett, T.F. Uliasz, A.S. Vidwans, and J.A. Hewett Cyclooxygenase-2 contributes to N-methyl-d-aspartate-mediated neuronal cell death in primary cortical cell culture J. Pharmacol. Exp. Ther. 293 2000 417 425
13. J.J. Hoozemans, M.K. Bruckner, A.J. Rozemuller, R. Veerhuis, P. Eikelenboom, and T. Arendt Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex J. Neuropathol. Exp. Neurol. 61 2002 678 688
14. C. Iadecola, and M. Alexander Cerebral ischemia and inflammation Curr. Opin. Neurol. 14 2001 89 94
15. C. Iadecola, K. Niwa, S. Nogawa, X. Zhao, M. Nagayama, E. Araki, S. Morham, and M.E. Ross Reduced susceptibility to ischemic brain injury and N-methyl-d-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice Proc. Natl. Acad. Sci. U. S. A. 98 2001 1294 1299
16. H. Ino, and T. Chiba Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo J. Neurosci. 21 2001 6086 6094
17. J. Katchanov, C. Harms, K. Gertz, L. Hauck, C. Waeber, L. Hirt, J. Priller, R. von Harsdorf, W. Bruck, H. Hortnagl, U. Dirnagl, P.G. Bhide, and M. Endres Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death J. Neurosci. 21 2001 5045 5053
18. K. Kawaguchi, and S.H. Graham Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion Brain Res. 749 1997 131 134
19. Y. Kitamura, S. Shimohama, H. Koike, J. Kakimura, Y. Matsuoka, Y. Nomura, P.J. Gebicke-Haerter, and T. Taniguchi Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-gamma in Alzheimer's disease brains Biochem. Biophys. Res. Commun. 254 1999 582 586
20. A.K. Konstantinidis, R. Radhakrishnan, F. Gu, R.N. Rao, and W.K. Yeh Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation J. Biol. Chem. 273 1998 26506 26515
21. S. Miettinen, F.R. Fusco, J. Yrjanheikki, R. Keinanen, T. Hirvonen, R. Roivainen, M. Narhi, T. Hokfelt, and J. Koistinaho Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-d-aspartic acid-receptors and phospholipase A2 Proc. Natl. Acad. Sci. U. S. A. 94 1997 6500 6505
22. M. Mirjany, L. Ho, and G.M. Pasinetti Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity J. Pharmacol. Exp. Ther. 301 2002 494 500
23. M. Nakayama, K. Uchimura, R.L. Zhu, T. Nagayama, M.E. Rose, R.A. Stetler, P.C. Isakson, J. Chen, and S.H. Graham Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia Proc. Natl. Acad. Sci. U. S. A. 95 1998 10954 10959
24. S. Nogawa, F. Zhang, E. Ross, and C. Iadecola Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage J. Neurosci. 14 1997 2746 2755
25. H. Osuga, S. Osuga, F. Wang, R. Fetni, M.J. Hogan, R.S. Slack, A.M. Hakim, J.E. Ikeda, and D.S. Park Cyclin-dependent kinases as a therapeutic target for stroke Proc. Natl. Acad. Sci. U. S. A. 97 2000 10254 10259
26. D.S. Park, E.J. Morris, L.A. Greene, and H.M. Geller G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis J. Neurosci. 17 1997 1256 1270
27. D.S. Park, E.J. Morris, J. Padmanabhan, M.L. Shelanski, H.M. Geller, and L.A. Greene Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents J. Cell Biol. 143 1998 457 467
28. Z.H. Qin, R.W. Chen, Y. Wang, M. Nakai, D.M. Chuang, and T.N. Chase Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum J. Neurosci. 19 1999 4023 4033
29. D.K. Resnick, S.H. Graham, C.E. Dixon, and D.W. Marion Role of cyclooxygenase 2 in acute spinal cord injury J. Neurotrauma 15 1998 1005 1013
30. T. Sairanen, A. Ristimaki, M.L. Karjalainen-Lindsberg, A. Paetau, M. Kaste, and P.J. Lindsberg Cyclooxygenase-2 is induced globally in infarcted human brain Ann. Neurol. 43 1998 738 747
31. O. Sanz, A. Estrada, I. Ferrer, and A.M. Planas Differential cellular distribution and dynamics of HSP70, cyclooxygenase-2, and c-Fos in the rat brain after transient focal ischemia or kainic acid Neuroscience 80 1997 221 232
32. K. Seibert, Y. Zhang, K. Leahy, S. Hauser, J. Masferrer, W. Perkins, L. Lee, and P. Isakson Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain Proc. Natl. Acad. Sci. U. S. A. 91 1994 12013 12017
33. A.M. Senderowicz The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01 Oncologist 7 Suppl. 3 2002 12 19
34. R.E. Shackelford, W.K. Kaufmann, and R.S. Paules Oxidative stress and cell cycle checkpoint function Free Radic. Biol. Med. 28 2000 1387 1404
35. D.W. Stacey Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells Curr. Opin. Cell Biol. 15 2003 158 163
36. W.F. Stewart, C. Kawas, M. Corrada, and E.J. Metter Risk of Alzheimer's disease and duration of NSAID use Neurology 48 1997 626 632
37. C. Tordjman, F. Coge, N. Andre, H. Rique, M. Spedding, and J. Bonnet Characterisation of cyclooxygenase 1 and 2 expression in mouse resident peritoneal macrophages in vitro; interactions of non steroidal anti-inflammatory drugs with COX2 Biochim. Biophys. Acta 1256 1995 249 256
38. S. Weggen, J.L. Eriksen, P. Das, S.A. Sagi, R. Wang, C.U. Pietrzik, K.A. Findlay, T.E. Smith, M.P. Murphy, T. Bulter, D.E. Kang, N. Marquez-Sterling, T.E. Golde, and E.H. Koo A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity Nature 414 2001 212 216
39. Z. Xiang, L. Ho, S. Yemul, Z. Zhao, W. Qing, P. Pompl, K. Kelley, A. Dang, D. Teplow, and G.M. Pasinetti Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer's disease neuropathology Gene Expr. 10 2002 271 278
40. T. Yagami, K. Ueda, K. Asakura, S. Hata, T. Kuroda, T. Sakaeda, N. Takasu, K. Tanaka, T. Gemba, and Y. Hori Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis Mol. Pharmacol. 61 2002 114 126
41. K. Yamagata, K.I. Andreasson, W.E. Kaufmann, C.A. Barnes, and P.F. Worley Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids Neuron 11 1993 371 386
42. T. Yamamoto, and N. Nozaki-Taguchi Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor Brain Res. 739 1996 104 110